About Aperta Biosciences
Aperta Biosciences is a company based in Austin (United States) founded in 2017 by Carlos Santos. It operates as a B2B. Aperta Biosciences offers products and services including APT-001.
- Headquarter Austin, United States
- Founders Carlos Santos
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Aperta Biosciences, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aperta Biosciences
Aperta Biosciences offers a comprehensive portfolio of products and services, including APT-001.
Ophthalmic suspension targeting demodicosis to treat blepharitis effectively
Funding Insights of Aperta Biosciences
Detailed funding history for Aperta Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aperta Biosciences
Investment portfolio details for Aperta Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aperta Biosciences
Detailed financials for Aperta Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aperta Biosciences Comparisons
Peer comparison for Aperta Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aperta Biosciences
Latest news on Aperta Biosciences
Complete news archive for Aperta Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aperta Biosciences
Aperta Biosciences was founded in 2017.
Aperta Biosciences is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Carlos Santos is the current CEO of Aperta Biosciences. They have also founded this company.
Aperta Biosciences is a biopharma company that focuses on creating new therapeutics for ocular surface diseases, including blepharitis, ocular rosacea, and dry eye. It targets underlying causes like demodicosis using reformulated drugs such as APT-001. Led by experienced professionals in ophthalmology, the company operates from Austin, Texas, aiming to address inflammation and prevent vision complications through research and development.
Aperta Biosciences offers APT-001.